Alnylam Act - No Charge, Third Party Genetic Testing & Counseling

June 27, 2019

Learn about Alnylam Act, Alnylam’s no charge, third party genetic testing and counseling service for individuals who may carry gene mutations known to be associated with either hereditary ATTR (hATTR) amyloidosis, acute hepatic porphyria (AHP), or primary hyperoxaluria type 1 (PH1). Get more information at AlnylamAct.com.

Spotlight

Doctible

Doctible is a healthcare SaaS platform for engaging patients and automating back-office workflow to help practices and health systems grow.

OTHER VIDEOS

Pharmacy Management System Project in Python Source Code

video | May 21, 2022

Pharmacy Management System Project in Python Source Code What is Pharmacy Management System Project in Python...

Watch Now

AI accelerated drug discovery

video | May 20, 2022

AI accelerated drug discovery, allowing for a fast-track discovery and repurposing of existing molecule, intelligent clinical design and coupled with in-house manufacturing....

Watch Now

Prescription Management System in SwilERP Pharmacy Software

video | May 27, 2022

Prescription Management is an essential task for the Pharmacist. The Prescription management feature of SwilERP Pharmacy Software enables the Pharmacists to create and maintain the medical records quickly and accurately evaluate the patient's health....

Watch Now

Accelerate Your Pharma 4.0 Journey with Our Manufacturing Execution Systems (MES) Solution

video | May 5, 2022

Today’s pharmaceutical manufacturers face increasing pressure to deliver high-quality medicines quickly, efficiently and economically while complying with regulatory requirements and meeting sustainability goals....

Watch Now

Spotlight

Doctible

Doctible is a healthcare SaaS platform for engaging patients and automating back-office workflow to help practices and health systems grow.

Events